Download PDF Company Provides Update on Tivozanib Clinical Program and Timelines CAMBRIDGE, Mass., Nov 02, 2011 (BUSINESS WIRE) — AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) today reported consolidated financial results for the third quarter of 2011 and provided an update on the tivozanib clinical program. “The last few months have been focused on executing on our